In his first 100 days as commissioner of the Food and Drug Administration, Marty Makary has made a handful of splashy ...

On July 10, 2025, the Food and Drug Administration (FDA) announced that it had published more than 200 complete response letters (CRLs), in ...

President John Dramani Mahama has named Professor Kwabena Frimpong-Manso Opuni as the new acting Chief Executive Officer of the Food and Drugs Authority (FDA), effective Monday, July 14, 2025. ‎ ‎In a ...

Zimmer Biomet Holdings Inc. and Monogram Technologies Inc., an orthopedic robotics company, have announced that they have ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced FDA approval for an update to its Varipulse platform's irrigation flow ...

First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting ...

Investing.com -- The U.S. Food and Drug Administration has approved gardenia (genipin) blue for use in various foods, marking the fourth natural color additive approved in the last two months.

The FDA published over 200 response letters sent as replies to drug and biological product applications in order to increase transparency.

Meanwhile, Bloomberg reports that the FDA may offer to fast-track drug reviews for companies that lower their U.S drug prices. Also: a billion-dollar backlog of delayed grants at HHS, and more.

GSK plc (GSK) said on Monday that its application for extending the use of its respiratory syncytial virus (RSV) vaccine ...

The Food and Drug Administration (FDA), in collaboration with the National Institutes of Health (NIH), hosted a workshop ...

Corcept Therapeutics has filed for U.S. Food and Drug Administration approval of its relacorilant drug candidate for the treatment of patients with platinum-resistant ovarian cancer.